Neurotoxic Effects of Neonicotinoids on Mammals: What Is There beyond the Activation of Nicotinic Acetylcholine Receptors?—A Systematic Review DOI Open Access
Carmen Costas‐Ferreira, L.R.F. Faro

International Journal of Molecular Sciences, Journal Year: 2021, Volume and Issue: 22(16), P. 8413 - 8413

Published: Aug. 5, 2021

Neonicotinoids are a class of insecticides that exert their effect through specific action on neuronal nicotinic acetylcholine receptors (nAChRs). The success these is due to this mechanism action, since they act as potent agonists insect nAChRs, presenting low affinity for vertebrate which reduces potential toxic risk and increases safety non-target species. However, although neonicotinoids considered safe, presence in the environment could increase exposure toxicity. On other hand, have mammalian large quantity, variety, ubiquity receptors, combined with its diversity functions, raises question what effects can produce In present systematic review, we investigate available evidence biochemical behavioral nervous system. general, at an early age alters correct development, decreases neurogenesis alterations migration, induces neuroinflammation. adulthood, induce neurobehavioral toxicity, being associated modulating consequent neurochemical alterations. These include decreased expression modifications acetylcholinesterase activity, significant changes function nigrostriatal dopaminergic All lead activation series intracellular signaling pathways generate oxidative stress, neuroinflammation and, finally, death. Neonicotinoid-induced nAChR be responsible most observed different studies.

Language: Английский

Neuroinflammation and depression: A review DOI
Romain Troubat, Pascal Barone, Samuel Leman

et al.

European Journal of Neuroscience, Journal Year: 2020, Volume and Issue: 53(1), P. 151 - 171

Published: March 9, 2020

Abstract Some recent clinical and preclinical evidence suggests that neuroinflammation is a key factor interacts with the three neurobiological correlates of major depressive disorder: depletion brain serotonin, dysregulation hypothalamus–pituitary–adrenal (HPA) axis alteration continuous production adult‐generated neurons in dentate gyrus hippocampus. This review discusses main players immunity as well how inflammation above mechanisms. It reported kynurenine (KYN) pathway favour its excitotoxic component HPA have common effect increasing extracellular glutamate levels neurotransmission, which can impact hippocampal neurogenesis. pathophysiological cascade appears to be triggered or sustained reinforced by any chronic inflammatory condition involving increased circulating markers are able cross blood–brain barrier activate microglia; it also consequence primary neuroinflammation, such neurodegenerative disorders early manifestations frequently symptoms. Further data indicate microglial activation may result from direct stress on vascular function. The intricated dynamic crosstalk between other relevant depression add therapeutic target for future strategies disorder.

Language: Английский

Citations

750

Diet and depression: exploring the biological mechanisms of action DOI
Wolfgang Marx, Melissa M. Lane, Meghan Hockey

et al.

Molecular Psychiatry, Journal Year: 2020, Volume and Issue: 26(1), P. 134 - 150

Published: Nov. 3, 2020

Language: Английский

Citations

454

Noninvasive hippocampal blood−brain barrier opening in Alzheimer’s disease with focused ultrasound DOI Creative Commons
Ali R. Rezai,

Manish Ranjan,

Pierre-François D’Haese

et al.

Proceedings of the National Academy of Sciences, Journal Year: 2020, Volume and Issue: 117(17), P. 9180 - 9182

Published: April 13, 2020

The blood–brain barrier (BBB) presents a significant challenge for treating brain disorders. hippocampus is key target novel therapeutics, playing an important role in Alzheimer’s disease (AD), epilepsy, and depression. Preclinical studies have shown that magnetic resonance (MR)-guided low-intensity focused ultrasound (FUS) can reversibly open the BBB facilitate delivery of targeted therapeutics. We report initial clinical trial results evaluating safety, feasibility, reversibility opening with FUS treatment entorhinal cortex (EC) patients early AD. Six subjects tolerated total 17 treatments no adverse events neither cognitive nor neurological worsening. Post-FUS contrast MRI revealed immediate sizable hippocampal parenchymal enhancement indicating opening, followed by closure within 24 h. average was 95% volume, which corresponds to 29% overall volume. demonstrate safely, noninvasively, transiently, reproducibly, focally mediate hippocampus/EC humans. This provides unique translational opportunity investigate therapeutic AD other conditions.

Language: Английский

Citations

267

Major depressive disorder DOI
Wolfgang Marx, Brenda W.J.H. Penninx, Marco Solmi

et al.

Nature Reviews Disease Primers, Journal Year: 2023, Volume and Issue: 9(1)

Published: Aug. 24, 2023

Language: Английский

Citations

241

Formation and integration of new neurons in the adult hippocampus DOI
Annina Denoth‐Lippuner, Sebastian Jessberger

Nature reviews. Neuroscience, Journal Year: 2021, Volume and Issue: 22(4), P. 223 - 236

Published: Feb. 25, 2021

Language: Английский

Citations

216

Tau accumulation in astrocytes of the dentate gyrus induces neuronal dysfunction and memory deficits in Alzheimer’s disease DOI
Kevin Richetin, Pascal Steullet,

Mathieu Pachoud

et al.

Nature Neuroscience, Journal Year: 2020, Volume and Issue: 23(12), P. 1567 - 1579

Published: Nov. 9, 2020

Language: Английский

Citations

174

Recalibrating the Relevance of Adult Neurogenesis DOI
Jason S. Snyder

Trends in Neurosciences, Journal Year: 2019, Volume and Issue: 42(3), P. 164 - 178

Published: Jan. 25, 2019

Language: Английский

Citations

172

Adult Hippocampal Neurogenesis in Major Depressive Disorder and Alzheimer’s Disease DOI
Thomas Berger, Hyun Ah Lee, Allan H. Young

et al.

Trends in Molecular Medicine, Journal Year: 2020, Volume and Issue: 26(9), P. 803 - 818

Published: May 15, 2020

Language: Английский

Citations

159

Restoring miR-132 expression rescues adult hippocampal neurogenesis and memory deficits in Alzheimer’s disease DOI Creative Commons
Hannah Walgrave, Sriram Balusu,

Sarah Snoeck

et al.

Cell stem cell, Journal Year: 2021, Volume and Issue: 28(10), P. 1805 - 1821.e8

Published: May 24, 2021

Neural stem cells residing in the hippocampal neurogenic niche sustain lifelong neurogenesis adult brain. Adult (AHN) is functionally linked to mnemonic and cognitive plasticity humans rodents. In Alzheimer's disease (AD), process of generating new neurons at impeded, yet mechanisms involved are unknown. Here we identify miR-132, one most consistently downregulated microRNAs AD, as a potent regulator AHN, exerting cell-autonomous proneurogenic effects neural their progeny. Using distinct AD mouse models, cultured human primary established cells, patient material, demonstrate that AHN directly affected by pathology. miR-132 replacement hippocampus restores relevant memory deficits. Our findings corroborate significance models reveal possible therapeutic potential targeting neurodegeneration.

Language: Английский

Citations

122

Neurogenesis in aging and age-related neurodegenerative diseases DOI Creative Commons

Luka Čulig,

Xixia Chu,

Vilhelm A. Bohr

et al.

Ageing Research Reviews, Journal Year: 2022, Volume and Issue: 78, P. 101636 - 101636

Published: April 29, 2022

Language: Английский

Citations

117